Pulmonary side effects of interferon-α therapy in patients with hematological malignanciesANDERSON, Patrik; HÖGLUND, Martin; RÖDJER, Stig et al.American journal of hematology. 2003, Vol 73, Num 1, pp 54-58, issn 0361-8609, 5 p.Article

Age and acute myeloid leukemia : real world data on decision to treat and outcomes from the Swedish Acute Leukemia RegistryJULIUSSON, Gunnar; ANTUNOVIC, Petar; DEROLF, Asa et al.Blood. 2009, Vol 113, Num 18, pp 4179-4187, issn 0006-4971, 9 p.Article

Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marksDENEBERG, Stefan; GUARDIOLA, Philippe; TIDEFELT, Ulf et al.Blood. 2011, Vol 118, Num 20, pp 5573-5582, issn 0006-4971, 10 p.Article

Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II studyJULIUSSON, Gunnar; HÖGLUND, Martin; KARLSSON, Karin et al.British journal of haematology. 2003, Vol 123, Num 5, pp 810-818, issn 0007-1048, 9 p.Article

Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008BJÖRKHOLM, Magnus; OHM, Lotta; KRISTINSSON, Sigurdur Y et al.Journal of clinical oncology. 2011, Vol 29, Num 18, pp 2514-2520, issn 0732-183X, 7 p.Conference Paper

Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemiaERIKSSON, Anna; HÖGLUND, Martin; LARSSON, Rolf et al.Biochemical pharmacology. 2010, Vol 80, Num 10, pp 1507-1516, issn 0006-2952, 10 p.Article

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA SequenceGENOVESE, Giulio; KÄHLER, Anna K; PURCELL, Shaun M et al.The New England journal of medicine. 2014, Vol 371, Num 26, pp 2477-2487, issn 0028-4793, 11 p.Article

Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006JULIUSSON, Gunnar; KARLSSON, Karin; MÖLLGARD, Lars et al.Cancer. 2011, Vol 117, Num 18, pp 4238-4246, issn 0008-543X, 9 p.Article

The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testingHAGLUND, Caroline; ALESKOG, Anna; HAKANSSON, Lena Douhan et al.Toxicology letters. 2010, Vol 194, Num 3, pp 102-107, issn 0378-4274, 6 p.Article

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemiaPORKKA, Kimmo; KOSKENVESA, Perttu; ECCERSLEY, Lydia et al.Blood. 2008, Vol 112, Num 4, pp 1005-1012, issn 0006-4971, 8 p.Article

Cryoglobulin-induced cytokine production via FcγRIIla : inverse effects of complement blockade on the production of TNF-α and IL-10. Implications for the growth of malignant B-cell clonesMATHSSON, Linda; TEJDE, Andreas; CARLSON, Kristina et al.British journal of haematology. 2005, Vol 129, Num 6, pp 830-838, issn 0007-1048, 9 p.Article

Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotypeFALK, Ingrid Jakobsen; FYRBERG, Anna; GREEN, Henrik et al.British journal of haematology. 2014, Vol 167, Num 5, pp 671-680, issn 0007-1048, 10 p.Article

Acute myeloid leukemia in the real world: why population-based registries are neededJULIUSSON, Gunnar; LAZAREVIC, Vladimir; HÖRSTEDT, Ann-Sofi et al.Blood. 2012, Vol 119, Num 17, pp 3890-3899, issn 0006-4971, 10 p.Article

In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissuesHAGLUND, Caroline; ALESKOG, Anna; NYGREN, Peter et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 3, pp 697-707, issn 0344-5704, 11 p.Article

Sex Differences in Fertility-Related Information Received by Young Adult Cancer SurvivorsARMUAND, Gabriela M; RODRIGUEZ-WALLBERG, Kenny A; WETTERGREN, Lena et al.Journal of clinical oncology. 2012, Vol 30, Num 17, pp 2147-2153, issn 0732-183X, 7 p.Article

Topoisomerase IIα mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemiaUGGLA, Bertil; TINA, Elisabet; NAHI, Hareth et al.International journal of oncology. 2007, Vol 31, Num 1, pp 153-160, issn 1019-6439, 8 p.Article

In vitro evaluation of the efficacy of idarubicin in human tumour cells from patients with low-grade non-Hodgkin's lymphomaALESKOG, Anna; JONSSON, Elin; LARSSON, Rolf et al.British journal of haematology. 2002, Vol 117, Num 3, pp 563-568, issn 0007-1048Article

Topoisomerase IIa expression in acute myeloid leukaemia cells that survive after exposure to daunorubicin or ara-CTINA, Elisabet; PRENKERT, Malin; HOGLUND, Martin et al.Oncology reports. 2009, Vol 22, Num 6, pp 1527-1531, issn 1021-335X, 5 p.Article